Screener
Medpace Holdings, Inc. MEDP Business Segments — Total direct costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DirectOperatingCosts.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Direct service costs, excluding depreciation and amortization - Employee compensation | 163,089 | 147,942 | 327,692 | 291,869 |
| Direct service costs, excluding depreciation and amortization - Other segment items (a) | 39,466 | 37,884 | 73,137 | 71,773 |
| Reimbursed out-of-pocket expenses | 303,139 | 237,472 | 615,143 | 439,876 |
| Total direct costs | 505,694 | 423,298 | 1,015,972 | 803,518 |
| Selling, general and administrative | 48,103 | 46,664 | 96,020 | 104,561 |
| Depreciation | 6,555 | 6,777 | 13,306 | 13,471 |
| Amortization | 155 | 237 | 310 | 473 |
| Total operating expenses | 560,507 | 476,976 | 1,125,608 | 922,023 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s business segments — total direct costs?
- Medpace Holdings, Inc. (MEDP) reported business segments — total direct costs of $505.69M in Q2 2026.
- How has Medpace Holdings, Inc.'s business segments — total direct costs changed year-over-year?
- Medpace Holdings, Inc.'s business segments — total direct costs increased by 19.5% year-over-year, from $423.3M to $505.69M.
- What is the long-term trend for Medpace Holdings, Inc.'s business segments — total direct costs?
- Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s business segments — total direct costs has grown at a 19.9% compound annual growth rate (CAGR), from $1.03B to $1.77B.
- What does business segments — total direct costs mean?
- Includes all costs directly attributable to the delivery of services within the reportable segment, such as clinical research personnel salaries, site monitoring expenses, and laboratory supplies. These costs fluctuate directly with the volume of clinical trials and projects currently in progress.
Ask your AI about Medpace Holdings, Inc.'s business segments — total direct costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude